Madopar in the complex therapy of ischemic insult
Odinak, M.M.; Vozniuk, I.A.; Kovalenko, P.A.; Lobzin, S.V.; Ianishevskiĭ, S.N.
Voenno-Meditsinskii Zhurnal 326(1): 35-39
2005
ISSN/ISBN: 0026-9050 PMID: 15754768 Document Number: 584530
Document emailed within 1 workday
Related Documents
Vlasova, I.M.; Dolmatova, E.V.; Koshelev, V.B.; Saletskiĭ, A.M. 2009: Effect of ischemic preconditioning in ischemic insult by estimating the damage to low-density lipoproteins of rat blood by spectroscopic methods Biofizika 54(5): 901-907Markov, K.M. 2013: Brain blood flow and cerebral insult. Part 2. Cerebral insult pathogenesis and therapy Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 2: 65-76
Belokurov, I.N.; Kamennyĭ, A.N. 1971: Hyperbaric oxygenation in the treatment of ischemic insult Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 71(11): 1632-1634
Grbavac, Z. 1989: The role of thrombocytes in the development of ischemic cerebrovascular insult Neurologija 38(2): 95-110
Szewaga, W.ło.M.; Andrijuk, L.W. 2003: Correlation between the nucleic acid homeostasis disorders and location of ischemic insult and its consequences Wiadomosci Lekarskie 56(9-10): 449-454
Davidenkova, E.F.; Shafran, M.G.; Grigor'eva, V.V.; Kolosova, N.N.; Liberman, I.S. 1984: Lipid peroxidation of the blood neutrophils of patients with an ischemic insult and myocardial infarct and of their relatives Klinicheskaia Meditsina 62(11): 79-81
Eisenlohr, J.J.; Gehlen, W. 1979: Quantitative measurement of muscle tone in patients with Parkinsonism before and during therapy with madopar Fortschritte der Neurologie Psychiatrie und Ihrer Grenzgebiete 47(7): 331-346
Ponomarenko, G.N.; Svistov, A.S.; Obrezan, A.G.; Morozov, S.L.; Vlasenko, S.V. 2003: Infrared laser therapy in complex treatment of patients with ischemic heart disease after aortocoronary bypass surgery Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 3: 18-21
Amosova, E.N.; Bereza, N.V.; Potapkova, I.V. 2002: Effect of complex therapy including ATP-long on left ventricular diastolic function in patients with ischemic heart disease at rest and under isometric load Likars'ka Sprava 2002(3-4): 48-51
Aurich, H. 1975: Physical therapy in cerebrovascular disorders (with special regard to physico-therapeutic measures after cerebrovascular insult) Zeitschrift für Arztliche Fortbildung 69(23): 1223-1225
Jansen, E.N.; Meerwaldtt, J.D. 1990: Madopar HBS in nocturnal symptoms of Parkinson's disease Advances in Neurology 53: 527-531
Vendrova, M.I.; Sadekov, R.A.; Golubev, V.L. 2000: Efficiency of new forms of madopar in Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 100(12): 46-48
Berdichevskiĭ, M.Ia.; Karmirian, S.A.; Aristova, L.A.; Geĭkov, I.I.; Miroshnichenko, V.E.; Miasnikova, L.L.; Badovskaia, L.A.; Latashko, V.M.; Ponomarenko, R.I. 2004: Use of sodium succinate in complex treatment of ischemic stroke Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 2004(Suppl 10): 57-60
Bondarenko, N.A.; Bondarenko, N.A. 1985: Behavior disorder in rats induced by Madopar and its pharmacological correction Farmakologiia i Toksikologiia 48(4): 31-34
Kamenetskiĭ, V.K. 1984: Treatment of patients with vascular parkinsonism with the preparations nakom and madopar Klinicheskaia Meditsina 62(4): 112-116
Vedenko, L.T. 1974: Use of RNA synthesis cofactors in complex treatment of patients with ischemic heart disease Vrachebnoe Delo 11: 38-41
Fressinaud, C.; Preux, P.M.; Milor, A.M.; Daunas, I.; Dumas, M.; Vallat, J.M. 1993: Familial complex myxoma-lentiginosis disclosed by probable transient ischemic accident Revue Neurologique (Paris) 149(3): 219-221
Birkmayer, W.; Riederer, P.; Ambrozi, L.; Youdim, M.B. 1977: Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study Lancet 1(8009): 439-443
Parkhisenko, I.A.; Glukhov, A.A. 2001: Use of ozone therapy and hydro-pressure technologies in complex intensive therapy of surgical sepsis Khirurgiia 4: 55-58
Shan, D.E.; Yeh, S.I. 1996: An add-on study of selegiline to Madopar in the treatment of parkinsonian patients with dose-related fluctuations: comparison between Jumexal and Parkryl Zhonghua Yi Xue Za Zhi 58(4): 264-268